Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatic Vein Thrombosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT06054451
What this trial is testing

Clinical Diagnosis and Pathological Spectrum of Porto-sinusoidal Vascular Disease in India

Who this might be right for
Portal HypertensionBudd-Chiari SyndromeNon-Cirrhotic Portal Hypertension+4 more
Post Graduate Institute of Medical Education and Research, Chandigarh 210
Large-scale testing (Phase 3)UnknownNCT02971345
What this trial is testing

Endovascular Brachytherapy Combined With Stent Placement and TACE for HCC With Main Portal Vein Tumor Thrombus

Who this might be right for
Hepatocellular CarcinomaPortal Vein Tumor Thrombus
Shanghai Zhongshan Hospital 253
Not applicableLooking for participantsNCT06624098
What this trial is testing

Early Transjugular Intrahepatic Portosystemic Shunt for Advanced Hepatocellular Carcinoma

Who this might be right for
Advanced Hepatocellular CarcinomaVariceal Bleeding
Sun Yat-sen University 22
Testing effectiveness (Phase 2)Study completedNCT01911000
What this trial is testing

Effectiveness and Safety of the Simultaneous Radiotherapy and Hyperthermia After Transarterial Chemoembolization in Hepatocellular Carcinoma Patients Combined With Portal Vein Tumor Thrombosis

Who this might be right for
Carcinoma. Hepatocellular
Samsung Medical Center 69
Testing effectiveness (Phase 2)UnknownNCT04169399
What this trial is testing

Toripalimab Plus Stereotactic Body Radiotherapy for HCC With PVTT

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 30
Not applicableLooking for participantsNCT06622031
What this trial is testing

TIPS Combined With Lenvatinib and PD-1 Inhibitor for Advanced HCC With Main Trunk PVTT

Who this might be right for
Hepatocellular CarcinomaPortal Vein Tumor ThrombusSystemic Therapy
Sun Yat-sen University 42
Large-scale testing (Phase 3)Study completedNCT02585713
What this trial is testing

Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism

Who this might be right for
Cerebral Vein ThrombosisDeep Vein ThrombosisGonadal Thrombosis+9 more
Academic and Community Cancer Research United 300
Testing effectiveness (Phase 2)Looking for participantsNCT06823375
What this trial is testing

SBRT With Immunotherapy and Atezo-Bev in HCC With Major Portal Vein Thrombosis

Who this might be right for
HCC
Chinese University of Hong Kong 40
Testing effectiveness (Phase 2)Study completedNCT00849264
What this trial is testing

Comprehensive Treatment for Different Types of Tumor Thrombi in the Portal Vein for Hepatocellular Carcinoma Patients

Who this might be right for
Hepatocellular CarcinomaPortal Vein Tumor Thrombus
Eastern Hepatobiliary Surgery Hospital 120
Not applicableStudy completedNCT05304455
What this trial is testing

Apixaban Prevents Portal Vein Thrombosis After Laparoscopic Splenectomy and Azygoportal Disconnection

Who this might be right for
CirrhosisSplenectomyVenous Thrombosis+1 more
Northern Jiangsu People's Hospital 40
Testing effectiveness (Phase 2)Study completedNCT05166239
What this trial is testing

HAIC Combine With Lenvatinib and PD-1 Inhibitors for Advanced HCC With PVTT

Who this might be right for
Hepatocellular CarcinomaPortal Vein Thrombosis
Peking University 66
Testing effectiveness (Phase 2)Study completedNCT05625893
What this trial is testing

Proton Beam Radiotherapy Followed by Tecentriq and Avastin for Primary Liver Cancer With Vp2-4 Portal Vein Invasion

Who this might be right for
Hepatocellular CarcinomaPortal Vein Thrombosis
Samsung Medical Center 63
Not applicableUnknownNCT01033578
What this trial is testing

Efficacy of Postoperative Adjuvant Treatments for Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis

Who this might be right for
Hepatocellular Carcinoma
Fudan University 260
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07187284
What this trial is testing

EDN Combined With TACE/HAIC and Second-Line Immune-Targeted Treatment Versus TACE/HAIC Alone in Locally Advanced HCC With Portal Vein Tumor Thrombosis After First-Line Therapy Failure: A Prospective, Multicenter, Randomized Controlled Trial

Who this might be right for
HCC - Hepatocellular Carcinoma
Zhongda Hospital 62
Large-scale testing (Phase 3)UnknownNCT04319484
What this trial is testing

Lenvatinib Following Liver Transplantation in Patients of Hepatocellular Carcinoma With Portal Vein Tumor Thrombus

Who this might be right for
Hepatocellular CarcinomaPortal Vein Tumor ThrombusLiver Transplantation
RenJi Hospital 108
Large-scale testing (Phase 3)WithdrawnNCT00238160
What this trial is testing

Surgery With or Without Hepatic Arterial Chemotherapy in Treating Patients With Liver Cancer

Who this might be right for
Localized Resectable Adult Primary Liver CancerStage III Childhood Liver Cancer
Kyoto University
Post-approval studies (Phase 4)Study completedNCT03007212
What this trial is testing

Outcome of Transarterial Chemo-embolization (TACE) in Hepatocellular Carcinoma Patients With Partial Portal Vein Thrombosis

Who this might be right for
Hepatocellular Carcinoma (HCC)
Ain Shams University 30
Post-approval studies (Phase 4)UnknownNCT02398357
What this trial is testing

The Effect of Anticoagulation After Endoscopic Therapy in Cirrhotic Patients With Portal Vein Thrombosis

Who this might be right for
Portal Vein ThrombosisLiver Cirrhosis
Shanghai Zhongshan Hospital 96
Large-scale testing (Phase 3)UnknownNCT03192644
What this trial is testing

The Impact on Recurrence Risk of Adjuvant Transarterial Chemoinfusion (TAI) Versus Adjuvant Transarterial Chemoembolization (TACE) for Patients With Hepatocellular Carcinoma And Portal Vein Tumor Thrombosis (PVTT) After Hepatectomy : A Random, Controlled, Stage III Clinical Trial.

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 162
Testing effectiveness (Phase 2)UnknownNCT03520257
What this trial is testing

The Study of Apatinib Plus Radiotherapy vs. Apatinib in the Treatment of Hepatocellular Carcinoma With BCLC-C Stage I and Stage II Portal Vein Tumor Thrombus

Who this might be right for
Hepatocellular Carcinoma
Guangxi Medical University 50
Next Page